Letko, Brosseau & Associates’s GE HealthCare GEHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-188,971
Closed -$15.5M 96
2023
Q1
$15.5M Buy
+188,971
New +$13.5M 0.29% 70

Other funds holding GEHC

Letko, Brosseau & Associates's GEHC Position: Q2 2023 in Review

Letko, Brosseau & Associates sold out of GE HealthCare (GEHC) in Q2 2023, closing a stake of 188,971 shares — an estimated $15.5M sold.

Letko, Brosseau & Associates first reported a position in GEHC in Q1 2023 and held it in 1 quarter. The position peaked at $15.5M in Q1 2023. 1,133 funds tracked by Wall St. Rank hold GEHC as of Q2 2023.

  • Letko, Brosseau & Associates reported no remaining GE HealthCare position as of Q2 2023 after selling out during the quarter.
  • Letko, Brosseau & Associates sold 188,971 GE HealthCare shares in Q2 2023, an estimated $15.5M.
  • Letko, Brosseau & Associates first reported a position in GE HealthCare in Q1 2023 and held it in 1 quarter.
  • Letko, Brosseau & Associates's GE HealthCare position peaked at $15.5M in Q1 2023.
  • 1,133 funds tracked by Wall St. Rank held GE HealthCare as of Q2 2023.

Based on Letko, Brosseau & Associates's 13F filing for Q2 2023, filed 10 Aug 2023.